RS55408B1 - Derivati kvinolina kao antibakterijski agensi - Google Patents

Derivati kvinolina kao antibakterijski agensi

Info

Publication number
RS55408B1
RS55408B1 RS20161121A RSP20161121A RS55408B1 RS 55408 B1 RS55408 B1 RS 55408B1 RS 20161121 A RS20161121 A RS 20161121A RS P20161121 A RSP20161121 A RS P20161121A RS 55408 B1 RS55408 B1 RS 55408B1
Authority
RS
Serbia
Prior art keywords
compound
alkyl
hydrogen
alkyloxy
use according
Prior art date
Application number
RS20161121A
Other languages
English (en)
Serbian (sr)
Inventor
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Jérôme Emile Georges Guillemont
Magali Madeleine Simone Motte
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of RS55408B1 publication Critical patent/RS55408B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20161121A 2005-06-28 2006-06-26 Derivati kvinolina kao antibakterijski agensi RS55408B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05105769 2005-06-28
EP06763891.6A EP1898910B1 (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents
PCT/EP2006/063556 WO2007000436A1 (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents

Publications (1)

Publication Number Publication Date
RS55408B1 true RS55408B1 (sr) 2017-04-28

Family

ID=35445742

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20161121A RS55408B1 (sr) 2005-06-28 2006-06-26 Derivati kvinolina kao antibakterijski agensi

Country Status (33)

Country Link
US (2) US20100204270A1 (enExample)
EP (1) EP1898910B1 (enExample)
JP (1) JP5193859B2 (enExample)
KR (1) KR101423229B1 (enExample)
CN (1) CN101252928B (enExample)
AP (1) AP2733A (enExample)
AR (1) AR057654A1 (enExample)
AU (1) AU2006263884B2 (enExample)
BR (1) BRPI0612534B8 (enExample)
CA (1) CA2612623C (enExample)
CY (1) CY1118515T1 (enExample)
DK (1) DK1898910T3 (enExample)
EA (1) EA014163B1 (enExample)
ES (1) ES2606772T3 (enExample)
HR (1) HRP20161704T1 (enExample)
HU (1) HUE031268T2 (enExample)
IL (1) IL188394A (enExample)
JO (1) JO3270B1 (enExample)
LT (1) LT1898910T (enExample)
ME (1) ME02690B (enExample)
MX (1) MX2008000082A (enExample)
MY (1) MY151030A (enExample)
NO (1) NO341283B1 (enExample)
NZ (1) NZ564339A (enExample)
PL (1) PL1898910T3 (enExample)
PT (1) PT1898910T (enExample)
RS (1) RS55408B1 (enExample)
SG (1) SG166799A1 (enExample)
SI (1) SI1898910T1 (enExample)
TW (1) TWI392494B (enExample)
UA (1) UA91549C2 (enExample)
WO (1) WO2007000436A1 (enExample)
ZA (1) ZA200711149B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790186B2 (en) 2009-07-21 2017-10-17 Trustees Of Dartmouth College Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection
CN104254527B (zh) 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
CN105037497B (zh) * 2015-03-27 2018-06-26 中牧实业股份有限公司 一种恩拉霉素的提纯方法
WO2017035288A1 (en) * 2015-08-27 2017-03-02 Trustees Of Dartmouth College Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DK2301544T3 (da) * 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
EP1753427B1 (en) * 2004-05-28 2008-04-02 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Also Published As

Publication number Publication date
ME02690B (me) 2017-10-20
EA200800152A1 (ru) 2008-06-30
CY1118515T1 (el) 2017-07-12
IL188394A (en) 2012-09-24
CA2612623A1 (en) 2007-01-04
JO3270B1 (ar) 2018-09-16
NZ564339A (en) 2011-02-25
AU2006263884A1 (en) 2007-01-04
ES2606772T3 (es) 2017-03-27
PT1898910T (pt) 2016-11-16
BRPI0612534A2 (pt) 2010-11-23
SI1898910T1 (sl) 2017-01-31
NO20080481L (no) 2008-02-29
AP2733A (en) 2013-09-30
KR101423229B1 (ko) 2014-07-25
MY151030A (en) 2014-03-31
AR057654A1 (es) 2007-12-12
JP2008546825A (ja) 2008-12-25
AU2006263884B2 (en) 2013-01-10
TW200738237A (en) 2007-10-16
HUE031268T2 (en) 2017-06-28
IL188394A0 (en) 2008-08-07
JP5193859B2 (ja) 2013-05-08
CN101252928A (zh) 2008-08-27
BRPI0612534B8 (pt) 2021-05-25
EP1898910B1 (en) 2016-09-28
ZA200711149B (en) 2009-06-24
SG166799A1 (en) 2010-12-29
NO341283B1 (no) 2017-10-02
PL1898910T3 (pl) 2017-03-31
BRPI0612534B1 (pt) 2020-04-22
HRP20161704T1 (hr) 2017-02-10
DK1898910T3 (en) 2017-01-09
US20100204270A1 (en) 2010-08-12
LT1898910T (lt) 2017-01-10
MX2008000082A (es) 2008-03-24
BRPI0612534A8 (pt) 2017-12-26
HK1120734A1 (en) 2009-04-09
EA014163B1 (ru) 2010-10-29
UA91549C2 (ru) 2010-08-10
CA2612623C (en) 2016-09-27
EP1898910A1 (en) 2008-03-19
WO2007000436A1 (en) 2007-01-04
US20130030017A1 (en) 2013-01-31
KR20080028460A (ko) 2008-03-31
TWI392494B (zh) 2013-04-11
CN101252928B (zh) 2012-05-23

Similar Documents

Publication Publication Date Title
TWI381839B (zh) 作為抗菌劑之喹啉衍生物(二)
JP5302680B2 (ja) 抗バクテリア剤としてのキノリン誘導体
CN101232884B (zh) 作为抗菌剂的喹啉衍生物
US20130030016A1 (en) Quinoline derivatives as antibacterial agents
US20130030017A1 (en) Quinoline derivatives as antibacterial agents
RS52606B (sr) Derivati kinolina kao antibakterijski agensi
RS52517B (sr) Kinolinski derivati kao antibakterijski agensi
US20100197727A1 (en) Quinoline Derivatives as Antibacterial Agents
MXPA05013412A (en) Quinoline derivatives as antibacterial agents
BG109179A (bg) Хинолинови производни като антибактериални средства